Climate Change Data

BioLife Solutions, Inc.

Climate Impact & Sustainability Data (2018)

Reporting Period: 2018

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Not disclosed

Environmental Achievements

  • Not disclosed

Social Achievements

  • Not disclosed

Governance Achievements

  • Not disclosed

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Limited availability of cell and gene therapy starting material, particularly in Europe due to regulations prohibiting monetary reimbursement of donors.
  • Variability in donor characteristics (age, disease state, medical history, genetics, lifestyle) impacting starting material quality.
  • Variability in leukapheresis collection methods and equipment across clinical sites.
  • Insufficient number of target cells in some leukapheresis collections due to factors like chemotherapy and insufficient collection volume.
  • Temperature sensitivity of cell therapy products and risk of cold chain disruptions during shipping.
Mitigation Strategies
  • Establishing a large, reliable donor database meeting FDA and cGMP/cGTP requirements.
  • Optimizing T cell isolation techniques.
  • Setting quality criteria for acceptable viable cell counts and immune cell subpopulation ratios.
  • Standardizing operating procedures and GMP/GTP compliant collection protocols.
  • Partnering with commercial suppliers of human blood products with standardized equipment, protocols, and training.
  • Utilizing collection protocols that enrich for the mononuclear cell (MNC) layer and deplete monocytes.
  • Employing effective biopreservation media to extend shelf life and optimize quality of starting material.
  • Implementing well-controlled freezing and thawing rates and consistent cryopreservation protocols.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Not disclosed

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed